Can Airsupra (fluticasone furoate and vilanterol) be used with an Ellipta (dry powder inhaler) device?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 29, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Airsupra and Ellipta Device Compatibility

No, Airsupra cannot be taken with an Ellipta device—these are two completely different products that are not interchangeable. Airsupra is a specific FDA-approved combination medication (albuterol/budesonide) delivered through its own proprietary metered-dose inhaler (MDI), while Ellipta is a dry powder inhaler (DPI) device used exclusively for other medications like Breo (fluticasone furoate/vilanterol).

Critical Distinction Between Products

Airsupra is not the same as Breo Ellipta, and the two should never be confused:

  • Breo Ellipta contains fluticasone furoate and vilanterol delivered via the Ellipta dry powder inhaler device 1
  • The Ellipta device is specifically designed as a "light grey and pale blue plastic inhaler containing 2 foil blister strips" that delivers medication as a dry powder 1
  • Breo Ellipta is administered as one inhalation once daily through the Ellipta device 1

Device-Specific Characteristics

The Ellipta device has unique operational requirements that make it incompatible with other medications:

  • Dry powder inhalers like Ellipta do not require spacers, unlike metered-dose inhalers 2
  • The Ellipta requires rapid (60 L/min or 1-2 seconds) deep inhalation for proper drug delivery 3
  • Patients must generate sufficient inspiratory flow to activate the inhaler—most children under 4 years cannot generate adequate flow 3
  • The Ellipta device delivers medication through breath-activation of pre-loaded blister strips containing specific drug formulations 1

Why Medications Cannot Be Interchanged Between Devices

Each inhaler device is engineered for specific drug formulations and cannot accommodate other medications:

  • Metered-dose inhalers (MDIs) use propellants to deliver medication and require coordination between actuation and slow (30 L/min or 3-5 seconds) deep inhalation 3
  • MDIs benefit from spacer devices to improve drug delivery to the lungs, while DPIs like Ellipta do not use spacers 3, 2
  • The Ellipta device contains pre-packaged medication in blister strips that cannot be replaced or substituted with other drugs 1

Common Pitfall to Avoid

Never attempt to use medications in devices other than those specifically designed and FDA-approved for that medication. Each combination of drug and device undergoes rigorous testing to ensure proper dosing, and using the wrong device could result in inadequate treatment, overdose, or complete treatment failure 1.

References

Guideline

Inhaler Device Characteristics and Spacer Requirements

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.